Anti-Inflammatory HDL Function and Incident Cardiovascular/Death Events: A Secondary Analysis of the JUPITER Trial

被引：0
|
作者：
Ajala, Oluremi N. [1 ]
Demler, Olga [1 ]
Farukhi, Zareen [1 ]
Liu, Yanyan [1 ]
Adelman, Steven [2 ]
Collins, Heidi [2 ]
Glynn, Robert [1 ]
Ridker, Paul [1 ]
Khera, Amit [3 ]
Rader, Dan [4 ]
Mora, Samia [1 ]
机构：
[1] Harvard Univ, Prevent Med, Boston, MA 02115 USA
[2] Vasc Strategies LLC, Vasc Strategies, Wynnewood, PA USA
[3] Harvard Univ, Cardiol, Boston, MA 02115 USA
[4] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Inflammation; HDL; Cardiovascular disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13310
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events
    Jia, Congzhuo
    Anderson, Josephine L. C.
    Gruppen, Eke G.
    Lei, Yu
    Bakker, Stephan J. L.
    Dullaart, Robin P. F.
    Tietge, Uwe J. F.
    CIRCULATION, 2021, 143 (20) : 1935 - 1945
  • [2] Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
    Riggs, Kayla A.
    Joshi, Parag H.
    Khera, Amit
    Singh, Kavisha
    Akinmolayemi, Oludamilola
    Ayers, Colby R.
    Rohatgi, Anand
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [3] Meta-analysis: Cardiovascular events associated with nonsteroidal anti-inflammatory drugs
    Salpeter, Shelley R.
    Gregor, Peter
    Ormiston, Thomas M.
    Whitlock, Richard
    Raina, Parminder
    Thabane, Lehana
    Topol, Eric J.
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (07) : 552 - 559
  • [4] Renal Function Impacts the Association Between HDL Particles and Incident Cardiovascular Events (Observations From the DHS)
    Chindhy, Shahzad
    Ayers, Colby
    Khera, Amit
    Joshi, Parag
    Rohatgi, Anand
    CIRCULATION, 2017, 136
  • [5] Anti-Inflammatory Therapy With Canakinumab and Reduction in Total Cardiovascular Events
    Everett, Brendan M.
    MacFadyen, Jean G.
    Thuren, Tom
    Libby, Peter
    Glynn, Robert J.
    Ridker, Paul
    CIRCULATION, 2018, 138
  • [6] Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
    Pende, Aldo
    Dallegri, Franco
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (01) : 27 - 36
  • [7] HDL Particle Subclasses, Rosuvastatin Therapy, and Risk of Vascular Events: An Analysis From the JUPITER Trial
    Akinkuolie, Akintunde O.
    Lawler, Patrick R.
    Glynn, Robert J.
    Ridker, Paul M.
    Mora, Samia
    CIRCULATION, 2015, 132
  • [8] Anti-Inflammatory Therapies to Prevent Cardiovascular Events: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Boczar, Kevin E.
    Shin, Sheojung
    Pearson, Alexander
    Shahab, Saba
    Geejo, Aishwarya
    Visintini, Sarah
    Fehlmann, Christophe
    Bezzina, Kathryn
    Beanlands, Rob S.
    Wells, George
    CIRCULATION, 2023, 148
  • [9] Group IIA Secretory Phospholipase A2, Vascular Inflammation, and Incident Cardiovascular Disease An Analysis From the JUPITER Trial
    Akinkuolie, Akintunde O.
    Lawler, Patrick R.
    Chu, Audrey Y.
    Caulfield, Michael
    Mu, Jianying
    Ding, Bo
    Nyberg, Fredrik
    Glynn, Robert J.
    Ridker, Paul M.
    Hurt-Camejo, Eva
    Chasman, Daniel I.
    Mora, Samia
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (06) : 1182 - 1190
  • [10] Protein Glycan Side-Chains, Rosuvastatin Therapy, and Incident Vascular Events: An Analysis from the JUPITER Trial
    Akinkuolie, Akintunde
    Glynn, Robert J.
    Ridker, Paul M.
    Mora, Samia
    CIRCULATION, 2014, 130
12345